Fresh Perspectives on Retinopathy Retinopathy remains the leading cause of vision loss in the global working population. Regardless of whether it is triggered by ischemia or diabetes, the late vision-threatening stage of retinopathy is marked by VEGF-mediated pathological neovascularization and concomitant vascular leakage. As such, anti-VEGF therapies have long been the preferred strategy to manage […]